TOPHACEOUS GOUT
Clinical trials for TOPHACEOUS GOUT explained in plain language.
Never miss a new study
Get alerted when new TOPHACEOUS GOUT trials appear
Sign up with your email to follow new studies for TOPHACEOUS GOUT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough gout cases: experimental combo targets stubborn uric acid
Disease control Recruiting nowThis study tests a new drug called AR882 combined with a standard gout medication (XOI) in 25 adults with uncontrolled gout who had severe reactions or failed uricase therapy. The goal is to lower uric acid levels below 6 mg/dL and shrink painful uric acid crystal deposits (tophi…
Matched conditions: TOPHACEOUS GOUT
Phase: PHASE2 • Sponsor: Arthrosi Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New gout drug aims to dissolve painful joint lumps
Disease control Recruiting nowThis study tests a new drug called dotinurad against the standard medication allopurinol in 250 adults with tophaceous gout—a severe form of gout with hard lumps under the skin. The main goal is to see if dotinurad lowers uric acid levels more effectively after 24 weeks. Particip…
Matched conditions: TOPHACEOUS GOUT
Phase: PHASE3 • Sponsor: Crystalys Therapeutics • Aim: Disease control
Last updated May 01, 2026 15:57 UTC